US FDA Chief Scientist Bumpus Will Become Principal Deputy Commissioner

 
• By Derrick Gingery

When Janet Woodcock retires early next year, Namandjé Bumpus will take over as No. 2 in command at the FDA. Since joining the agency in 2022 from Johns Hopkins, her profolio has included health disparities, cosmetics, and drug review disputes.

leadership promotion
Namandjé Bumpus will help complete the reorganization of the FDA's Human Foods Program and ORA. • Source: Shutterstock

More from US FDA

More from Agency Leadership